Comment on an article: "Coagulopathy in COVID-19".
Journal of thrombosis and haemostasis : JTH(2020)
摘要
We have read with great attention the article "Coagulopathy in COVID-19" written by Toshiaki Iba et al. (Authors), published in the September issue of Journal (1). The Authors performed an effective and informative review. Nevertheless, we welcome the opportunity to make a short comment as well. This very interesting article evaluates current literature regarding harmful hypercoagulable milieu of COVID-19. Surprisingly, we can not see that the Authors recommended other diagnostic considerations such a checking for hyperhomocysteinemia in patients with COVID-19. Undoubtedly, hyperhomocysteinemia has neurotoxic, neuroinflammatory, neurodegenerative, prooxidative, as well as proatherogenic/ prothrombotic effects.
更多查看译文
关键词
COVID-19,coagulopathy,folic acid,homocysteine,vitamin B12
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要